The catalytic subunit of DNA-PK regulates transcription and splicing of AR in advanced prostate cancer

被引:7
作者
Adamson, Beth [1 ]
Brittain, Nicholas
Walker, Laura [1 ]
Duncan, Ruaridh [1 ]
Luzzi, Sara [2 ]
Rescigno, Pasquale [1 ]
Smith, Graham [3 ]
McGill, Suzanne [4 ]
Burchmore, Richard J. S. [4 ]
Willmore, Elaine [1 ]
Hickson, Ian [1 ]
Robson, Craig N. [1 ]
Bogdan, Denisa [5 ]
Jimenez-Vacas, Juan M. [5 ]
Paschalis, Alec [5 ,6 ]
Welti, Jonathan [5 ,6 ]
Yuan, Wei [5 ,6 ]
McCracken, Stuart R. [1 ]
Heer, Rakesh [1 ,7 ]
Sharp, Adam [5 ,6 ]
de Bono, Johann S. [5 ,6 ]
Gaughan, Luke [1 ]
机构
[1] Newcastle Univ, Ctr Canc, Paul OGorman Bldg, Newcastle Upon Tyne, England
[2] Newcastle Univ, Biosci Inst, Int Ctr Life, Newcastle Upon Tyne, England
[3] Newcastle Univ, Bioinformat Support Unit, Med Sch, Newcastle Upon Tyne, England
[4] Univ Glasgow, Coll Med Vet & Life Sci, Wolfson Wohl Canc Res Ctr, Glasgow Poly, Glasgow City, Scotland
[5] Inst Canc Res, London, England
[6] Royal Marsden NHS Fdn Trust, London, England
[7] Imperial Coll London, Div Surg, London, England
关键词
ANDROGEN RECEPTOR GENE; PROTEIN-KINASE; TELOMERE LENGTH; VARIANT; 7; RNA; EXPRESSION; PHOSPHORYLATION; PROGRESSION; ABIRATERONE; DOMAIN;
D O I
10.1172/JCI169200
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Aberrant androgen receptor (AR) signaling drives prostate cancer (PC), and it is a key therapeutic target. Although initially effective, the generation of alternatively spliced AR variants (AR-Vs) compromises efficacy of treatments. In contrast to full-length AR (AR-FL), AR-Vs constitutively activate androgenic signaling and are refractory to the current repertoire of durable PC therapies that can attenuate AR-V function. Exploiting the requirement of coregulatory proteins for AR-V function has the capacity to furnish tractable routes for attenuating persistent oncogenic AR signaling in advanced PC. DNA-PKcs regulates AR-FL transcriptional activity and is upregulated in both early and advanced PC. We hypothesized that DNA-PKcs is critical for AR-V function. Using a proximity biotinylation approach, we demonstrated that the DNA-PK holoenzyme is part of the AR-V7 interactome and is a key regulator of AR-V-mediated transcription and cell growth in models of advanced PC. DNA-PKcs blockade is an effective therapeutic option in advanced AR-V-positive patients with PC.
引用
收藏
页数:19
相关论文
共 65 条
[1]   The Molecular Taxonomy of Primary Prostate Cancer [J].
Abeshouse, Adam ;
Ahn, Jaeil ;
Akbani, Rehan ;
Ally, Adrian ;
Amin, Samirkumar ;
Andry, Christopher D. ;
Annala, Matti ;
Aprikian, Armen ;
Armenia, Joshua ;
Arora, Arshi ;
Auman, J. Todd ;
Balasundaram, Miruna ;
Balu, Saianand ;
Barbieri, Christopher E. ;
Bauer, Thomas ;
Benz, Christopher C. ;
Bergeron, Alain ;
Beroukhim, Rameen ;
Berrios, Mario ;
Bivol, Adrian ;
Bodenheimer, Tom ;
Boice, Lori ;
Bootwalla, Moiz S. ;
dos Reis, Rodolfo Borges ;
Boutros, Paul C. ;
Bowen, Jay ;
Bowlby, Reanne ;
Boyd, Jeffrey ;
Bradley, Robert K. ;
Breggia, Anne ;
Brimo, Fadi ;
Bristow, Christopher A. ;
Brooks, Denise ;
Broom, Bradley M. ;
Bryce, Alan H. ;
Bubley, Glenn ;
Burks, Eric ;
Butterfield, Yaron S. N. ;
Button, Michael ;
Canes, David ;
Carlotti, Carlos G. ;
Carlsen, Rebecca ;
Carmel, Michel ;
Carroll, Peter R. ;
Carter, Scott L. ;
Cartun, Richard ;
Carver, Brett S. ;
Chan, June M. ;
Chang, Matthew T. ;
Chen, Yu .
CELL, 2015, 163 (04) :1011-1025
[2]   Genomic correlates of clinical outcome in advanced prostate cancer [J].
Abida, Wassim ;
Cyrta, Joanna ;
Heller, Glenn ;
Prandi, Davide ;
Armenia, Joshua ;
Coleman, Ilsa ;
Cieslik, Marcin ;
Benelli, Matteo ;
Robinson, Dan ;
Van Allen, Eliezer M. ;
Sboner, Andrea ;
Fedrizzi, Tarcisio ;
Mosquera, Juan Miguel ;
Robinson, Brian D. ;
De Sarkar, Navonil ;
Kunju, Lakshmi P. ;
Tomlins, Scott ;
Wu, Yi Mi ;
Rodrigues, Daniel Nava ;
Loda, Massimo ;
Gopalan, Anuradha ;
Reuter, Victor E. ;
Pritchard, Colin C. ;
Mateo, Joaquin ;
Bianchini, Diletta ;
Miranda, Susana ;
Carreira, Suzanne ;
Rescigno, Pasquale ;
Filipenko, Julie ;
Vinson, Jacob ;
Montgomery, Robert B. ;
Beltran, Himisha ;
Heath, Elisabeth I. ;
Scher, Howard I. ;
Kantoff, Philip W. ;
Taplin, Mary-Ellen ;
Schultz, Nikolaus ;
deBono, Johann S. ;
Demichelis, Francesca ;
Nelson, Peter S. ;
Rubin, Mark A. ;
Chinnaiyan, Arul M. ;
Sawyers, Charles L. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (23) :11428-11436
[3]   Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration- Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide [J].
Antonarakis, Emmanuel S. ;
Lu, Changxue ;
Luber, Brandon ;
Wang, Hao ;
Chen, Yan ;
Zhu, Yezi ;
Silberstein, John L. ;
Taylor, Maritza N. ;
Maughan, Benjamin L. ;
Denmeade, Samuel R. ;
Pienta, Kenneth J. ;
Paller, Channing J. ;
Carducci, Michael A. ;
Eisenberger, Mario A. ;
Luo, Jun .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (19) :2149-+
[4]   Darolutamide antagonizes androgen signaling by blocking enhancer and super-enhancer activation [J].
Baumgart, Simon J. ;
Nevedomskaya, Ekaterina ;
Lesche, Ralf ;
Newman, Richard ;
Mumberg, Dominik ;
Haendler, Bernard .
MOLECULAR ONCOLOGY, 2020, 14 (09) :2022-2039
[5]   ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response [J].
Blackford, Andrew N. ;
Jackson, Stephen P. .
MOLECULAR CELL, 2017, 66 (06) :801-817
[6]   FUS/TLS Is a Novel Mediator of Androgen-Dependent Cell-Cycle Progression and Prostate Cancer Growth [J].
Brooke, Greg N. ;
Culley, Rachel L. ;
Dart, D. Alwyn ;
Mann, David J. ;
Gaughan, Luke ;
McCracken, Stuart R. ;
Robson, Craig N. ;
Spencer-Dene, Bradley ;
Gamble, Simon C. ;
Powell, Sue M. ;
Wait, Robin ;
Waxman, Jonathan ;
Walker, Marjorie M. ;
Bevan, Charlotte L. .
CANCER RESEARCH, 2011, 71 (03) :914-924
[7]   Discovery and characterization of small molecules targeting the DNA-binding ETS domain of ERG in prostate cancer [J].
Butler, Miriam S. ;
Roshan-Moniri, Mani ;
Hsing, Michael ;
Lau, Desmond ;
Kim, Ari ;
Yen, Paul ;
Mroczek, Marta ;
Nouri, Mannan ;
Lien, Scott ;
Axerio-Cilies, Peter ;
Dalal, Kush ;
Yau, Clement ;
Ghaidi, Fariba ;
Guo, Yubin ;
Yamazaki, Takeshi ;
Lawn, Sam ;
Gleave, Martin E. ;
Gregory-Evans, Cheryl Y. ;
McIntosh, Lawrence P. ;
Cox, Michael E. ;
Rennie, Paul S. ;
Cherkasov, Artem .
ONCOTARGET, 2017, 8 (26) :42438-42454
[8]   Androgen Receptor Gene Expression in Prostate Cancer Is Directly Suppressed by the Androgen Receptor Through Recruitment of Lysine-Specific Demethylase 1 [J].
Cai, Changmeng ;
He, Housheng Hansen ;
Chen, Sen ;
Coleman, Ilsa ;
Wang, Hongyun ;
Fang, Zi ;
Chen, Shaoyong ;
Nelson, Peter S. ;
Liu, X. Shirley ;
Brown, Myles ;
Balk, Steven P. .
CANCER CELL, 2011, 20 (04) :457-471
[9]   Autophosphorylation of the DNA-dependent protein kinase catalytic subunit is required for rejoining of DNA double-strand breaks [J].
Chan, DW ;
Chen, BPC ;
Prithivirajsingh, S ;
Kurimasa, A ;
Story, MD ;
Qin, J ;
Chen, DJ .
GENES & DEVELOPMENT, 2002, 16 (18) :2333-2338
[10]   Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 [J].
Chen, Zhong ;
Wu, Dayong ;
Thomas-Ahner, Jennifer M. ;
Lu, Changxue ;
Zhao, Pei ;
Zhang, Qingfu ;
Geraghty, Connor ;
Yan, Pearlly S. ;
Hankey, William ;
Sunkel, Benjamin ;
Cheng, Xiaolong ;
Antonarakis, Emmanuel S. ;
Wang, Qi-En ;
Liu, Zhihua ;
Huang, Tim H-M ;
Jin, Victor X. ;
Clinton, Steven K. ;
Luo, Jun ;
Huang, Jiaoti ;
Wang, Qianben .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (26) :6810-6815